Flexible Stenting Solutions has announced that it has received CE mark approval for its FlexStent Iliac Self Expanding Stent System indicated for the treatment of symptomatic atherosclerotic disease of the common and/or external iliac arteries.
The FlexStent family of peripheral vascular stent systems now includes stent diameters of 5, 6, 7, 8, 9 and 10mm, and offers the physician additional options in the treatment of patients with peripheral artery disease (PAD) of the iliac, superficial femoral and popliteal arteries.
As with the FlexStent Femoropopliteal Self Expanding Stent System, the FlexStent Iliac Self Expanding Stent System is an innovative, nearly fully connected, flexible, strong and durable nitinol stent delivered from a straightforward stent delivery system. In addition to simplicity and ease of use, the 6 French / .035” over the wire delivery system provides the physician with a means for very accurate stent deployment.
“The extension of the FlexStent family of peripheral vascular stents to include sizes indicated for the treatment of the iliac artery is one more realization of the utility of this truly unique stent design platform. Flexible Stenting Solutions continued goal is to work towards expansion of the indications of this unique stent and simplify the peripheral vascular stenting procedure so the physician can focus on the patient,” said Janet Burpee, CEO, Flexible Stenting Solutions.
Market launch of the FlexStent Iliac Self Expanding Stent System in Europe is expected in the third quarter of 2012.
